A Critique in Need of Critique

Public Health Ethics 3 (2):178-185 (2010)
Abstract
Is it really necessary to add something like the Health Impact Fund to the existing global patent system? We can divide this question into two parts. First, is there something seriously wrong with the status quo and, if so, what exactly is it? Second, how do we best go about solving the problem; that is, how does the design of the reform proposal address the flaws in the status quo? Jorn Sonderholm, in his critique of the Health Impact Fund, or HIF, raises both of these issues. These criticisms afford us the opportunity to reaffirm our commitment to ameliorating glaring problems with the current system for incentivizing R&D for essential medicines, and to clarify why we believe the HIF is exactly what the world needs
Keywords No keywords specified (fix it)
Categories (categorize this paper)
Reprint years 2010
DOI 10.1093/phe/php037
Options
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 29,820
Through your library
References found in this work BETA
Human Rights and Global Health: A Research Program.Thomas W. Pogge - 2005 - Metaphilosophy 36 (1‐2):182-209.

Add more references

Citations of this work BETA
Patent Funded Access to Medicines.Tom Andreassen - 2015 - Developing World Bioethics 15 (3):152-161.

Add more citations

Similar books and articles
Added to PP index
2010-08-11

Total downloads
24 ( #230,036 of 2,210,175 )

Recent downloads (6 months)
1 ( #385,054 of 2,210,175 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature